Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.6K
Overview
44.6K
Development of Immunocompetence01:22

Development of Immunocompetence

324
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
324
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

959
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
959
Prevalence and Incidence01:08

Prevalence and Incidence

593
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
593
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

105
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
105

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Retraction Note: Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Annual immunisation coverage report 2024.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2024 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2025 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same journal

Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016.

Communicable diseases intelligence (2018)·2026
Same journal

Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024.

Communicable diseases intelligence (2018)·2026
Same journal

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same journal

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
查看所有相关文章

相关实验视频

Updated: Jul 14, 2025

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K

年度免疫覆盖率报告2021年

Brynley Hull1, Alexandra Hendry2, Aditi Dey2

  • 1National Centre for Immunisation Research and Surveillance. The Children's Hospital at Westmead and The University of Sydney. brynley.hull@health.nsw.gov.au.

Communicable diseases intelligence (2018)
|October 11, 2023
PubMed
概括
此摘要是机器生成的。

澳大利亚儿童和青少年接种疫苗的覆盖率在2021年仍然很高,但观察到一些下降,可能是由于COVID-19大流行. 成年人接种疫苗的覆盖率,特别是流感和疹疫苗,需要改进.

关键词:
疫苗接种覆盖率 疫苗接种覆盖率疫苗接种及时性 疫苗接种及时性原住民和托雷斯海峡岛民的疫苗接种覆盖率流感疫苗接种 流感疫苗接种接种COVID-19疫苗的时间

更多相关视频

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

相关实验视频

Last Updated: Jul 14, 2025

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 公共卫生 公共卫生
  • 流行病学 流行病学

背景情况:

  • 澳大利亚免疫登记处 (AIR) 收集儿童,青少年和成人的疫苗接种数据.
  • 了解疫苗接种趋势对于公共卫生倡议和疾病预防至关重要.

研究的目的:

  • 分析2021年澳大利亚疫苗接种覆盖率数据,并与前几年进行比较.
  • 确定COVID-19大流行对不同年龄组的疫苗接种率的趋势和潜在影响.

主要方法:

  • 分析澳大利亚免疫注册表 (AIR) 2021年日历年份数据.
  • 儿童,青少年和成人疫苗接种覆盖率与前几年数据的比较.
  • 检查不同年龄里程碑和人口群体的疫苗接种趋势,包括土著人口和具有不同社会经济优势的地区.

主要成果:

  • 与2020年相比,2021年儿童疫苗接种覆盖率略有下降,在6-59个月的儿童中,流感疫苗接种率显著下降.
  • 在一个日历年内完成青少年人类乳头瘤病毒 (HPV) 疫苗接种量在2021年显著下降,可能是由于大流行导致学校课程中断.
  • 成年人接种疫苗的覆盖率有所不同,疹疫苗和13vPCV疫苗的比率相对较低,而COVID-19疫苗接种率很高,特别是在老年人群中. 接种流感疫苗的覆盖率随着年龄的增长而增加.

结论:

  • 虽然儿童和青少年的整体疫苗接种覆盖率仍然很高,但COVID-19大流行显示出一些影响,特别是及时的HPV疫苗接种.
  • 需要加强对成年人疫苗接种计划的重视,以提高低于最佳的覆盖率.
  • 需要进一步评估,以评估强制性报告对AIR数据完整性的影响.